Dr. Rahul Gupta, director of the Office of National Drug Control Policy, is overseeing a progressive drug control strategy that largely rests on the concept of harm reduction, experts tell The New York Times. Read more
A new study finds over-the-counter cannabidiol (CBD) products often contain more or less CBD than is indicated on the label, HealthDay reports. Read more
The nation’s supply of the opioid addiction medication methadone declined significantly during the pandemic, while the supply of buprenorphine increased, according to a new study. Read more
